Results 151 to 160 of about 3,957 (191)

Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas. [PDF]

J Immunother Cancer
Monti M, Picinoli S, Bozzola A, Ferrari M, Bugatti M, Pezzali I, Carlomagno M, Carta G, Orlandi M, Lora G, Benerini Gatta L, Missale F, Ferrari G, Baldazzi V, Rezzola S, Tabellini G, Parolini S, Manfredi M, De Giorgis V, Marengo E, Turri-Zanoni M, Nicolai P, Consoli F, Lombardi D, Martini P, Li J, Griffith O, Griffith M, Rossato M, Vermi W.   +29 more
europepmc   +1 more source

B and T Tumor-Infiltrating Lymphocyte Subtypes According to Subsite: A Colon Cancer Immunophenotyping Map. [PDF]

Biomedicines
Fagarasan G, Gheban BA, Fagarasan V, Crisan D, Telecan T, Bintintan VV, Seicean RI, Caziuc A, Dindelegan GC.   +8 more
europepmc   +1 more source

Tumor Immune Microenvironment and Current Status of Immune Checkpoint Inhibitor Therapy in Colorectal Cancer Liver Metastasis. [PDF]

Curr Oncol
Cao D, Zhou A.
europepmc   +1 more source

Estimating tumour immune infiltration: methodological convergence across histology and spatial technologies. [PDF]

Brief Bioinform
Bian B, Cao Y, Yang JYH.
europepmc   +1 more source

Combined immunoscore and pan-immune inflammation value associated with pathological response and survival outcomes in esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy. [PDF]

Int J Surg
Huang JS, Zhong QH, Zhang YQ, Zhang HY, Guo FL, Wu JY, Chen S, Lin WW, Zhang ZY, Lin JB.   +9 more
europepmc   +1 more source

Biomarker-guided immuno-angiogenic therapy in biliary tract cancer: insights from IMbrave151. [PDF]

J Gastrointest Oncol
Cisarovsky C, Chau I.
europepmc   +1 more source

The Huchang-Barrier framework: an integrative perspective on the spatial features of the tumor invasive front. [PDF]

Med Rev (2021)
Xie D, Li Z, Li J, Hu K.
europepmc   +1 more source

Predictive biomarkers for immune checkpoint inhibition for patients with colorectal cancer: a comprehensive review. [PDF]

Immunotherapy
Sahin IH, Saridogan T, Kim R.
europepmc   +1 more source

Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1. [PDF]

J Immunother Cancer
Middleton G, Gaskell C, Savage J, Bridgewater J, Ross P, Saunders M, Palmer D, Plummer R, Clive S, Coyle V, Thomas A, Cunningham D, Taniere P, Billingham L.   +13 more
europepmc   +1 more source

From biology to morphology and treatment: the current role of pathology in penile cancer - a narrative review. [PDF]

Front Oncol
Hrudka J, Zavillová N, Hojný J, Waldauf P, Matěj R.   +4 more
europepmc   +1 more source